poisar

Stocks · News reference

Lipocine Q2 EPS $(0.32) Beats $(0.43) Estimate, Sales $190.099K Beat $156.500K Estimate

Aug 4, 2026, 10:19 AMBenzinga Newsdesk

Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.43) by 25.58 percent. This is a 21.95 percent increase over losses of $(0.41) per share from the

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

LPCN
Source
benzinga
Observed
Aug 4, 2026, 10:19 AM
Checked
Aug 4, 2026, 10:19 AM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Aug 21, 2026, 8:30 PMSEC EDGAR

    8-K/A filing — Lipocine Inc. (LPCN)

    Filed: 2026-08-21 AccNo: 0001493152-26-039689 Size: 257 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    Read original at edgar
    LPCN